February 14, 2023
VIA EDGAR
Division of Corporation Finance
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Margaret Schwartz, Attorney Adviser
Re: Nava Health MD, Inc.
Registration Statement on Form S-1
File No. 333-268022
Acceleration Request
Requested Date: February 14, 2023
Requested Time: 4:00 P.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Nava Health MD, Inc. (the “Registrant”) hereby requests that the above-referenced Registration Statement on Form S-1 (File No. 333-268022) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Registrant or its counsel may orally request (the “Registration Statement Acceleration Request”) via telephone call to the staff (the “Staff”) of the Division of Corporation Finance of the Securities and Exchange Commission (the “Commission”). The Registrant hereby authorizes Eric R. Smith of Venable LLP, counsel for the Registrant, to make such request on the Registrant’s behalf.
We request that we be notified of the effectiveness of the Registration Statement by telephone to Christopher E. Conn of Venable LLP at 410-244-7718, or in his absence, Eric R. Smith of Venable LLP at 410-528-2355. Thank you for your assistance.
| |
| Very truly yours, |
| |
| /s/ Bernaldo Dancel |
| Bernaldo Dancel, |
| Chief Executive Officer |
cc: Eric R. Smith (Venable LLP)
Rachel M. Jones (Venable LLP)
Christopher E. Conn (Venable LLP)